Romain Chautard - Publications

Data on microRNA transcriptomic signatures, predicted gene targets and pathway analysis in response to cetuximab or panitumumab in colorectal cancer cells.

Journal: Data in brief

Published: January 21, 2026

Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: December 18, 2025

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.

Journal: The oncologist

Published: February 13, 2025

Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 15, 2024

Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: December 14, 2023

Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.

Journal: British journal of clinical pharmacology

Published: September 25, 2023

Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.

Journal: Clinical pharmacokinetics

Published: May 28, 2023

Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 08, 2023

Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.

Journal: Clinics and research in hepatology and gastroenterology

Published: December 30, 2022

Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: from preclinical to clinical studies.

Journal: Expert opinion on drug delivery

Published: April 01, 2022

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.

Journal: International journal of molecular sciences

Published: February 25, 2022

Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.

Journal: Cellular and molecular life sciences : CMLS

Published: January 31, 2022